Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Apelin ELISA Kit (AC3678)
Cat.#: ASET-2267
Specifications
Description Human Apelin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Apelin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.47 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1944 Human ATP7A ELISA Kit (AC3355) Quantitative inquiry ASET-1300 Mouse Metabotropic Glutamate Receptor 5 ELISA Kit (AC2711) Quantitative inquiry ASET-2141 Mouse AKR7A2 ELISA Kit (AC3552) Quantitative inquiry ASET-2069 Mouse Neurotensin ELISA Kit (AC3480) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1319 Guinea Pig BDNF ELISA Kit (AC2730) Quantitative inquiry ASET-1002 Human HDL ELISA Kit (AC2413) Quantitative inquiry ASET-1140 Human MT3 ELISA Kit (AC2551) Quantitative inquiry ASET-2135 Human SNAP23 ELISA Kit (AC3546) Quantitative inquiry ASET-2079 Mouse EGR2 ELISA Kit (AC3490) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket